FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2960576789> ?p ?o ?g. }

• W2960576789 endingPage "265" @default.
• W2960576789 startingPage "255" @default.
• W2960576789 abstract "Abstract: A majority of existing studies have focused on the efficacy of inhaled long-acting bronchodilators (ILABs), such as long-acting muscarinic antagonists (LAMAs) and long-acting β2–agonists (LABAs), and LABAs combined with LAMAs in treating chronic obstructive pulmonary disease (COPD). The current meta-analysis aimed to investigate the correlation of ILABs with specific cardiovascular adverse events (CAEs). Five electronic databases, including PubMed, Embase, Cochrane Library, Scopus, and Web of Science were systematically retrieved. Finally, 16 randomized controlled trials were enrolled into the current meta-analysis. Typically, the efficacy of 3 major classes of drugs (LABAs, LAMAs, and LABAs combined with LAMAs), and 7 specific drugs (including formoterol, glycopyrrolate, indacaterol, olodaterol, Salmeterol, tiotropium, and vilanterol) for 4 CAEs, including myocardial infarction, cardiac failure (CF), ischemic heart disease (IHD), and stroke in stable COPD patients, was examined. All the pooled results were analyzed through the odds ratios (ORs) with the corresponding 95% confidence intervals (CIs). The direct meta-analysis results suggested that LABAs could increase the risk of CF in patients with stable COPD compared with placebo controls (OR 1.70, 95% CI, 1.00–2.90). In addition, network meta-analysis results indicated that LAMAs combined with LABAs would result in an increased risk of CF in patients with stable COPD (OR 2.31, 95% CI, 1.10–5.09). According to the ILABs specific drug analysis, formoterol may potentially have protective effects on IHD compared with placebo controls (OR 0.45, 95% CI, 0.18–1.00). In conclusion, among these 3 kinds of ILABs, including LAMAs, LABAs, and LABAs/LAMAs, for stable COPD patients, LAMAs and LABAs are associated with the least possibility to induce myocardial infarction and stroke, respectively. However, the application of LABAs will probably increase the risk of CF; they should be used with caution for stable COPD patients with CF. In addition, in specific-drug analysis, the use of formoterol can reduce the risk of treatment-related IHD. Nevertheless, more studies on different drug doses are needed in the future to further validate this conclusion." @default.
• W2960576789 created "2019-07-23" @default.
• W2960576789 creator A5012190714 @default.
• W2960576789 creator A5014273442 @default.
• W2960576789 creator A5050672158 @default.
• W2960576789 creator A5062043706 @default.
• W2960576789 creator A5076626946 @default.
• W2960576789 date "2019-09-01" @default.
• W2960576789 modified "2023-10-16" @default.
• W2960576789 title "Correlation of Inhaled Long-Acting Bronchodilators With Adverse Cardiovascular Outcomes in Patients With Stable COPD" @default.
• W2960576789 cites W1580052802 @default.
• W2960576789 cites W1593428479 @default.
• W2960576789 cites W1802331233 @default.
• W2960576789 cites W1934734999 @default.
• W2960576789 cites W1950043623 @default.
• W2960576789 cites W1954671479 @default.
• W2960576789 cites W1972285749 @default.
• W2960576789 cites W1980177930 @default.
• W2960576789 cites W1980789906 @default.
• W2960576789 cites W1984582438 @default.
• W2960576789 cites W2014032502 @default.
• W2960576789 cites W2027918137 @default.
• W2960576789 cites W2039237831 @default.
• W2960576789 cites W2055569485 @default.
• W2960576789 cites W2057713439 @default.
• W2960576789 cites W2058580481 @default.
• W2960576789 cites W2066616351 @default.
• W2960576789 cites W2070935883 @default.
• W2960576789 cites W2084883728 @default.
• W2960576789 cites W2089834473 @default.
• W2960576789 cites W2110783271 @default.
• W2960576789 cites W2115278431 @default.
• W2960576789 cites W2126772717 @default.
• W2960576789 cites W2126930838 @default.
• W2960576789 cites W2130890836 @default.
• W2960576789 cites W2133080325 @default.
• W2960576789 cites W2134091333 @default.
• W2960576789 cites W2134398120 @default.
• W2960576789 cites W2135917172 @default.
• W2960576789 cites W2141034778 @default.
• W2960576789 cites W2142449488 @default.
• W2960576789 cites W2162627911 @default.
• W2960576789 cites W2163247562 @default.
• W2960576789 cites W2164281047 @default.
• W2960576789 cites W2289083244 @default.
• W2960576789 cites W2293917369 @default.
• W2960576789 cites W2344148139 @default.
• W2960576789 cites W2345348650 @default.
• W2960576789 cites W2558903543 @default.
• W2960576789 cites W2579827621 @default.
• W2960576789 cites W2580440154 @default.
• W2960576789 cites W2588781854 @default.
• W2960576789 cites W2606915282 @default.
• W2960576789 cites W2737947210 @default.
• W2960576789 cites W2764241369 @default.
• W2960576789 cites W2782011123 @default.
• W2960576789 cites W2890549075 @default.
• W2960576789 cites W4293860347 @default.
• W2960576789 cites W4294215472 @default.
• W2960576789 doi "https://doi.org/10.1097/fjc.0000000000000705" @default.
• W2960576789 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31306366" @default.
• W2960576789 hasPublicationYear "2019" @default.
• W2960576789 type Work @default.
• W2960576789 sameAs 2960576789 @default.
• W2960576789 citedByCount "7" @default.
• W2960576789 countsByYear W29605767892020 @default.
• W2960576789 countsByYear W29605767892021 @default.
• W2960576789 countsByYear W29605767892022 @default.
• W2960576789 crossrefType "journal-article" @default.
• W2960576789 hasAuthorship W2960576789A5012190714 @default.
• W2960576789 hasAuthorship W2960576789A5014273442 @default.
• W2960576789 hasAuthorship W2960576789A5050672158 @default.
• W2960576789 hasAuthorship W2960576789A5062043706 @default.
• W2960576789 hasAuthorship W2960576789A5076626946 @default.
• W2960576789 hasConcept C126322002 @default.
• W2960576789 hasConcept C127413603 @default.
• W2960576789 hasConcept C142724271 @default.
• W2960576789 hasConcept C156957248 @default.
• W2960576789 hasConcept C164705383 @default.
• W2960576789 hasConcept C168563851 @default.
• W2960576789 hasConcept C197934379 @default.
• W2960576789 hasConcept C204787440 @default.
• W2960576789 hasConcept C27081682 @default.
• W2960576789 hasConcept C2776042228 @default.
• W2960576789 hasConcept C2776136866 @default.
• W2960576789 hasConcept C2776478404 @default.
• W2960576789 hasConcept C2776780178 @default.
• W2960576789 hasConcept C2778884479 @default.
• W2960576789 hasConcept C2779871671 @default.
• W2960576789 hasConcept C2780645631 @default.
• W2960576789 hasConcept C2781018748 @default.
• W2960576789 hasConcept C42219234 @default.
• W2960576789 hasConcept C71924100 @default.
• W2960576789 hasConcept C78519656 @default.
• W2960576789 hasConcept C95190672 @default.
• W2960576789 hasConceptScore W2960576789C126322002 @default.
• W2960576789 hasConceptScore W2960576789C127413603 @default.
• W2960576789 hasConceptScore W2960576789C142724271 @default.

• next